» Non-Financial

Company Directors
Company Advisors
New & Press Releases
Directors Share Dealings
Major Shareholders
Company Subsidiary Calendar of Future Events
Company Name Change
Company Status Change

» Analyst Spreadsheet

Quick View(PDF)
Trader(PDF)
Dossier(PDF)
Download Analyst Template
Analyst Spreadsheet
Download Master Template
Annual Master Spreadsheet
Quarterly Master Spreadsheet
Annual & Quaterly Master Spreadsheet
Valuation Model Template
Valuation Model Spreadsheet
Business Risk(PDF)
Credit Metrics(PDF)
Annual Reports

For all products and/or service inquiries or to learn more about how WVB customer service solutions can reduce your service costs while increasing customer satisfaction, email us at .

THERAPIX BIO

WVB Number : ISR000030633 Country : State of Israel
SIC categorization : PHARMACEUTICAL PREPARATIONS (2834) ISIN : IL0010951403, US88339A2033
FT categorization : HEALTH CARE (431)  
Company status: ACTIVE  

» Corporation Profile :

Profile in brief:
The Company is an Israel-based company that develops biopharmaceutical products aimed at improving the effectiveness or administration of vaccines.
Phone : 972 03 6167055 Fax : 03 6167056
Chairman: : N/A Auditor : KOST FORER GABBAY & KASIERER
CEO/Managing Director : HABER HILEL ELRAN

» Company Facts

Net Profit Margin (%) N/A  
Operating Margin (%) N/A  
Return on Assets (%) -120.67  
Return on Equity (%) -201.35  
Employees 11  

» Company Financials

  Annual (2018)
Income Statement
('000 USD )
Sales/Total Revenue 0  
EBITDA -9,176  
EBIT -9,232  
Net Income -8,523  
Balance Sheet
( '000 USD)
Total Current Assets 2,430  
Total Assets 4,560  
Current Liabilities 4,483  
Total Liabilities & Debt 4,483  
Total Equity 77  
Cash & Flow
( '000 USD)
Net Income/Staring Line -8,949  
Cash from Operating -7,132  
Cash from Investing -2,094  
Cash from Financing 1,536  
Cash & Equivalent Yr End 1,485